97,476 Shares in Phreesia, Inc. (NYSE:PHR) Purchased by Nicholas Company Inc.

Nicholas Company Inc. purchased a new position in shares of Phreesia, Inc. (NYSE:PHR) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 97,476 shares of the company’s stock, valued at approximately $2,452,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Champlain Investment Partners LLC boosted its holdings in Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after purchasing an additional 97,847 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the last quarter. State Street Corp boosted its holdings in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Phreesia by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company’s stock valued at $12,415,000 after purchasing an additional 46,209 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now directly owns 115,633 shares of the company’s stock, valued at approximately $3,076,994.13. This represents a 1.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total transaction of $103,901.12. Following the completion of the sale, the general counsel now directly owns 142,630 shares in the company, valued at approximately $4,238,963.60. This represents a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 163,322 shares of company stock valued at $4,631,915. Insiders own 5.80% of the company’s stock.

Phreesia Price Performance

Shares of PHR opened at $25.37 on Friday. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The firm’s 50 day moving average price is $27.31 and its 200 day moving average price is $23.98. The company has a market cap of $1.47 billion, a P/E ratio of -17.26 and a beta of 1.03. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Thursday. Citigroup boosted their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Piper Sandler reissued an “overweight” rating and issued a $33.00 price target (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.